Search research articles
Contact Us
Filters
Showing results (221-230 of 1,725) with videos related to
Page
of 173
Sort By:
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
September 1, 1988
Early biochemical events in leukocyte activation
R R Sandborg, J E Smolen
Journal of Pharmaceutical Sciences
|
April 1, 1972
Determination of CMC from liquid junction potential measurements
E J Williams, V F Smolen
Journal of Pharmaceutical Sciences
|
July 1, 1971
Drug-absorption analysis from pharmacological data. II. Transcorneal biophasic availability of tropicamide
R D Schoenwald, V F Smolen
Journal of Pharmaceutical Sciences
|
October 1, 1974
Drug absorption analysis from pharmacological data. III: influence of polymers and pH on transcorneal biophasic availability and mydriatic response of tropicamide
V F Smolen, R D Schoenwald
Zeitschrift Fur Rheumatologie
|
February 24, 2006
[Measuring disease activity for rheumatoid arthritis]
D Aletaha, T Stamm, J Smolen
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
December 22, 2007
The burden of rheumatoid arthritis and access to treatment: uptake of new therapies
B Jönsson, G Kobelt, J Smolen
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
December 22, 2007
Patient access to rheumatoid arthritis treatments
Bengt Jönsson, Gisela Kobelt, Josef Smolen
Arthritis Research & Therapy
|
August 11, 2006
Interleukin-6: a new therapeutic target
Josef S Smolen, Ravinder N Maini
Rheumatic Diseases Clinics of North America
|
November 16, 2023
Charles L Christian: Model Physician Scientist and Mentor
Mary K Crow, Josef S Smolen
British Journal of Rheumatology
|
February 4, 1998
Should the clinician have interest in the deregulation of apoptosis in autoimmunity?
W B Graninger, J S Smolen
Page
of 173
Search research articles
Search
Showing results (221-230 of 1,725) with videos related to
Sort By:
Page
of 173
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
September 1, 1988
Early biochemical events in leukocyte activation
R R Sandborg, J E Smolen
Journal of Pharmaceutical Sciences
|
April 1, 1972
Determination of CMC from liquid junction potential measurements
E J Williams, V F Smolen
Journal of Pharmaceutical Sciences
|
July 1, 1971
Drug-absorption analysis from pharmacological data. II. Transcorneal biophasic availability of tropicamide
R D Schoenwald, V F Smolen
Journal of Pharmaceutical Sciences
|
October 1, 1974
Drug absorption analysis from pharmacological data. III: influence of polymers and pH on transcorneal biophasic availability and mydriatic response of tropicamide
V F Smolen, R D Schoenwald
Zeitschrift Fur Rheumatologie
|
February 24, 2006
[Measuring disease activity for rheumatoid arthritis]
D Aletaha, T Stamm, J Smolen
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
December 22, 2007
The burden of rheumatoid arthritis and access to treatment: uptake of new therapies
B Jönsson, G Kobelt, J Smolen
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
December 22, 2007
Patient access to rheumatoid arthritis treatments
Bengt Jönsson, Gisela Kobelt, Josef Smolen
Arthritis Research & Therapy
|
August 11, 2006
Interleukin-6: a new therapeutic target
Josef S Smolen, Ravinder N Maini
Rheumatic Diseases Clinics of North America
|
November 16, 2023
Charles L Christian: Model Physician Scientist and Mentor
Mary K Crow, Josef S Smolen
British Journal of Rheumatology
|
February 4, 1998
Should the clinician have interest in the deregulation of apoptosis in autoimmunity?
W B Graninger, J S Smolen
Page
of 173